Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EBI-005

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objective: Topical interleukin (IL)-1 receptor (R)1 blockade is therapeutically active in reducing signs and symptoms of dry eye… Expand
2016
2016
Presentation #2307 /Poster #C0121, ARVO Annual Meeting, Session #: 113, Session Title: Allergic conjunctivitis / Corneal… Expand
2015
2015
Objectives: Many allergic conjunctivitis (AC) patients are inadequately treated with conventional therapies or require steroids… Expand
2015
2015
Presentation #4488/Poster #A0114, ARVO Annual Meeting, Session #: 438, Session Title: Dry eye disease, II, Wednesday, May 6, 2015… Expand
2014
2014
There remains a substantial unmet medical need in the treatment of ocular surface inflammatory disorders, such as moderate to… Expand
2013
2013
1 Eleven Biotherpeutics, Cambridge, MA, United States. 2 Ophthalmology, Duke University School of Medicine, Durham, NC, United… Expand
2013
2013
IL-1 is a key inflammatory and immune mediator in many diseases, including dry-eye disease, and its inhibition is clinically… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2012
2012
Dry eye syndrome (DES) is an ocular surface inflammatory condition induced by desiccating stress and mediated by IL-1 stimulation… Expand